The SOCRATES Trial

Ticagrelor is an antiplatelet therapy that is an alternative to aspirin for preventing recurrent stroke. Does ticagrelor produce better outcomes than aspirin? New research findings are summarized in a new NEJM Quick Take video. Learn more at